Natl Sci Open
Volume 1, Number 1, 2022
Special Topic: COVID-19: Virus, Immunity and Vaccines
|Number of page(s)||5|
|Section||Life Sciences and Medicine|
|Published online||24 March 2022|
One year of COVID-19 vaccination
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
* Corresponding author (email: firstname.lastname@example.org)
Revised: 6 January 2022
Accepted: 18 January 2022
The year 2021 saw the development and deployment of COVID-19 vaccines at an unprecedented pace, which is a remarkable success in science and technology. COVID-19 vaccines based on different technology platforms have been given to billions of humans globally to minimize the infection and transmission of SARS-CoV-2, and most importantly, to end the COVID-19 pandemic. Here, we provide a snapshot of the current status and future challenge of COVID-19 vaccination after one year.
Key words: SARS-CoV-2 / COVID-19 / vaccine / VOCs / immune response
© The Author(s) 2022. Published by China Science Publishing & Media Ltd. and EDP Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.